AI Healthcare Market Hits $36.9 Billion — Projected $110B by 2030

The global artificial intelligence in healthcare market reached $36.9 billion in 2025, according to MarketsAndMarkets’ annual sector analysis — a figure that reflects compound annual growth of approximately 38.6% since 2020. The projection to $110.6 billion by 2030 implies sustained growth at similar rates, driven by continued FDA authorization, expanding clinical adoption, and the entry of large technology companies into health AI infrastructure.

The Data Behind the Numbers

MarketsAndMarkets segments the AI healthcare market across several categories: AI in medical imaging ($8.2B, largest segment), AI-powered drug discovery ($6.4B), natural language processing in clinical documentation ($5.8B), AI in hospital workflow optimization ($4.3B), and AI in personalized medicine ($3.7B). The remaining revenue spans remote patient monitoring analytics, AI-enabled clinical trials, and health insurance AI applications.

North America accounts for 54% of global market revenue, driven by the U.S. regulatory environment (FDA’s active authorization program), the depth of private health system investment in technology, and the concentration of leading AI health companies. Europe represents 23% of market share, with accelerating growth driven by NHS AI adoption programs and EU Digital Health Strategy investments. Asia-Pacific accounts for 18%, growing rapidly in China, Japan, and India.

Why 38.6% CAGR Is Credible

Sustained compound annual growth rates above 30% are rare in mature markets — but the AI healthcare market has structural characteristics that support this trajectory.

First, the base is growing: more patients, more digital health data, more connected devices. The global volume of medical imaging data alone grows by approximately 30% per year. More data creates more AI training opportunities and more deployment contexts.

Second, reimbursement expansion is unlocking adoption. CMS’s remote patient monitoring codes (2019), the 2024 AI-powered clinical decision support reimbursement guidance, and private insurer coverage decisions are converting AI from a cost center to a revenue opportunity for health systems — changing the adoption calculus.

“The single biggest unlock for health AI in 2024 was not a technology development — it was a billing code. When CMS pays for AI-assisted care, hospital CFOs pay attention.” — Health technology analyst, 2025

Big Tech Enters the Arena

The 2024–2025 period saw major technology company commitments to health AI infrastructure that will shape the market over the projection horizon. Microsoft’s deployment of Azure Health Data Services and DAX Copilot across hundreds of U.S. health systems, Google’s Med-PaLM 2 partnerships with Mayo Clinic and HCA Healthcare, and Amazon’s AWS health AI infrastructure expansion all represent capital commitments of billions of dollars annually.

These investments compress the time from AI research to clinical deployment, lower the technical infrastructure cost for mid-size health systems, and accelerate the standardization of AI implementation practices.

Market Risks

The projection to $110 billion rests on assumptions that carry risk. Regulatory headwinds — particularly the EU AI Act’s August 2026 compliance deadline — may slow European market growth. Liability uncertainty around AI-assisted diagnosis (who is responsible when an AI-aided diagnosis is wrong?) remains a deterrent to adoption in litigious healthcare markets. And the ongoing challenge of demonstrating patient outcome improvement (not just efficiency gain) will face increasing scrutiny from payers and health technology assessment bodies.

The market will grow. Whether it reaches $110B by 2030 or $85B or $130B depends on how efficiently the clinical implementation infrastructure matures — which is ultimately a human and organizational challenge, not a technological one.

Sources: MarketsAndMarkets, AI in Healthcare Market Report, 2025. CMS Physician Fee Schedule reimbursement updates, 2024. Microsoft, Google, Amazon health AI investment announcements, 2024–2025.